ICH-Q10: A Recipe for the Product Life Cycle - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

ICH-Q10: A Recipe for the Product Life Cycle
The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing.

Pharmaceutical Technology


1. ICH, ICH Q8 Pharmaceutical Development (ICH, Geneva, Nov. 10, 2005), http://www.ich.org/LOB/media/MEDIA1707.pdf, accessed Aug. 15, 2007.

2. ICH, ICH Q9 Quality Risk Management (ICH, Geneva, Nov. 9, 2005), http://www.ich.org/LOB/media/MEDIA1957.pdf, accessed Aug. 15, 2007.

3. ICH, ICH Q10 Draft Consensus Guideline Pharmaceutical Quality System (ICH, Geneva, May 9, 2007), http://www.ich.org/LOB/media/MEDIA3917.pdf, accessed Aug. 15, 2007.

4. J.C. Famulare, "Pharmaceutical Quality Systems, PQS, Enhanced by QbD for the Product Life Cycle," presented at the ISPE PQLI Workshop, Crystal City, VA, June 2007.

5. FDA, Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations (FDA, Rockville, MD, September 2006), http://www.fda.gov/cder/guidance/7260fnl.htm, accessed Aug. 1, 2007.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans
Source: Pharmaceutical Technology,
Click here